InvestorsHub Logo

guay

08/13/20 9:12 AM

#24506 RE: guay #24505

Can someone explain how an facility specifically designed for a global pandemic to manufacture vaccines at a rate of 700M doses a year does not conjure any interest by big pharma to produce. The only thing I am seeing is foreign companies receiving contracts $IBIO @TomIsett


https://publish.twitter.com/?query=https%3A%2F%2Ftwitter.com%2Ftbroussard08%2Fstatus%2F1293885870853033986&widget=Tweet